About this trial
There are public health expectations for the development of outpatient surgery and increased comfort and quality of care for the patient. In this study, we are interested in evaluating the feasibility of an outpatient hepatectomy with a a close and secure follow-up at home: through a connected platform and a follow-up by a nurse. The primary endpoint is the rate of re-hospitalization due to a postoperative complication before Day 30 and the rate of conversion to conventional hospitalization (= early failure of outpatient management). This single-center study will includes prospectively 20 patients requiring liver resection of up to 2 segments. The primary endpoint is the rate of re-hospitalization due to a postoperative complication before Day 30 and the rate of conversion to conventional hospitalization (= early failure of outpatient management).
Eligibility criteria
Qualifiers
Male or female, 18 to 69 years old
Indication for a minor laparoscopic hepatectomy (benign or malignant liver tumor, requiring resection of 1 or 2 segments maximum)
Membership in a social security system or beneficiary
Having given free and informed consent)
Disqualifiers
Patient living alone and without anyone at home during the first 7 days at home
Patient unable to be escorted home by a responsible adult upon discharge
Non-French speaking patient
Uncompliant patient
Trial design
Treatments tested in this trial
- Domomedicine and dedicated nursing care for a close and secure monitoring after an ambulatory hepatectomy